13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001697013
申报总市值
US$19.3亿
US$19.3亿
68 檔
21.8%
截至 Q2 2025 季度末，Eversept Partners, LP 的美股持仓估值约为 US$19.3亿，全数申报仓位共有 68 档。
在 Q2 2025，Eversept Partners, LP 操作展现出积极扩展与加仓意向。本季共新建仓 19 个新仓位，并对 23 个既有持股进行加仓（合计增持 42 档），相较减仓与清仓仓位显著占优。
在资产配置集中度方面，Eversept Partners, LP 的前 5 大核心持股（包含 NTRA, QQQ, GSK 等）合计占整体申报市值的 21.8%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NTRA | Natera Inc | 股票-医疗保健 | 12.37% | -1.58% | -10.89% | |
| 2 | QQQ | Invesco Qqq Trust Series 1 | ETF-科技型 | 8.74% | -3.49% | +16.66% | |
| 3 | GSK | Gsk Plc-spon Adr | 股票-医疗保健 | 7.92% | -3.89% | -14.52% | |
| 4 | VERA | Vera Therapeutics Inc | 股票-其他 | 5.16% | +0.32% | +25.50% | |
| 5 | RVTY | Revvity Inc | 股票-医疗保健 | 4.54% | +0.09% | +70.63% | |
| 6 | PCVX | Vaxcyte Inc | 股票-其他 | 3.88% | -0.93% | +133.10% | |
| 7 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 3.52% | +0.01% | -34.44% | |
| 8 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 3.50% | -0.38% | -3.49% | |
| 9 | BRKR | Bruker CORP | 股票-医疗保健 | 3.18% | +0.35% | +68.12% | |
| 10 | VRDN | Viridian Therapeutics Inc | 股票-其他 | 2.45% | +0.05% | +38.10% | |
| 11 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 2.14% | +0.23% | +13.90% | |
| 12 | CNC | Centene CORP | 股票-医疗保健 | 1.99% | -0.19% | EXIT | |
| 13 | INSP | Inspire Medical Systems Inc | 股票-医疗保健 | 1.96% | — | -11.78% | |
| 14 | CYH | Community Health Systems Inc | 股票-其他 | 1.92% | +0.01% | -27.35% | |
| 15 | AVTR | Avantor Inc | 股票-医疗保健 | 1.89% | -1.23% | EXIT | |
| 16 | TECH | Bio-techne CORP | 股票-医疗保健 | 1.87% | -0.28% | +40.71% | |
| 17 | TVTX | Travere Therapeutics Inc | 股票-其他 | 1.79% | +1.50% | +61.11% | |
| 18 | ZIMV | Zimvie Inc | 股票-其他 | 1.79% | — | — | |
| 19 | UNH | Unitedhealth Group Inc | 股票-医疗保健 | 1.74% | +0.53% | — | |
| 20 | ILMN | Illumina Inc | 股票-医疗保健 | 1.74% | — | — | |
| 21 | TEVA | Teva Pharmaceutical-sp Adr | 股票-医疗保健 | 1.62% | — | -25.37% | |
| 22 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.57% | +0.46% | +20.42% | |
| 23 | UTHR | United Therapeutics CORP | 股票-医疗保健 | 1.57% | -0.17% | +3.27% | |
| 24 | HQY | Healthequity Inc | 股票-医疗保健 | 1.50% | -0.23% | EXIT | |
| 25 | IQV | Iqvia Holdings Inc | 股票-医疗保健 | 1.41% | — | — | |
| 26 | PTGX | Protagonist Therapeutics Inc | 股票-其他 | 1.41% | +0.37% | NEW | |
| 27 | DVAX | Dynavax Technologies CORP | 股票-其他 | 1.09% | — | — | |
| 28 | MIRM | Mirum Pharmaceuticals Inc | 股票-其他 | 1.09% | — | — | |
| 29 | BCRX | Biocryst Pharmaceuticals Inc | 股票-其他 | 1.00% | -0.56% | -44.41% | |
| 30 | EOLS | Evolus Inc | 股票-其他 | 0.99% | — | — | |
| 31 | HUM | Humana Inc | 股票-医疗保健 | 0.98% | +0.64% | NEW | |
| 32 | GERN | Geron CORP | 股票-其他 | 0.95% | -0.24% | — | |
| 33 | GMED | Globus Medical Inc - A | 股票-医疗保健 | 0.92% | — | -12.05% | |
| 34 | ICLR | ICON Public Limited Company | 股票-医疗保健 | 0.86% | -0.40% | EXIT | |
| 35 | NAMS | NewAmsterdam Pharma Company N.V. | 股票-其他 | 0.69% | — | +47.51% | |
| 36 | ELV | Elevance Health Inc | 股票-医疗保健 | 0.68% | — | +20.79% | |
| 37 | REGN | Regeneron Pharmaceuticals | 股票-医疗保健 | 0.64% | — | — | |
| 38 | ✓ | Merus N V | 股票-其他 | 0.63% | — | +86.16% | |
| 39 | MOH | Molina Healthcare Inc | 股票-医疗保健 | 0.56% | +0.73% | -13.21% | |
| 40 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 0.51% | — | — | |
| 41 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 0.47% | — | — | |
| 42 | DHR | Danaher CORP | 股票-医疗保健 | 0.43% | — | — | |
| 43 | LQDA | Liquidia CORP | 股票-其他 | 0.41% | +0.42% | +138.46% | |
| 44 | GKOS | Glaukos CORP | 股票-医疗保健 | 0.30% | -0.13% | -80.19% | |
| 45 | ZBIO | Zenas Biopharma Inc | 股票-其他 | 0.29% | — | -26.96% | |
| 46 | NKTR | Nektar Therapeutics | 股票-其他 | 0.27% | — | — | |
| 47 | ALEC | Alector Inc | 股票-其他 | 0.26% | — | +221.67% | |
| 48 | AMRN | Amarin CORP PLC -adr | 股票-其他 | 0.25% | +0.01% | — | |
| 49 | MNKD | Mannkind CORP | 股票-其他 | 0.24% | — | — | |
| 50 | ETNBGBP | 89bio Inc | 股票-其他 | 0.21% | — | -22.30% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | PCVX | Vaxcyte Inc | +1.7% | +133.10% | 加仓 |
| 2 | UNH | Unitedhealth Group Inc | +1.7% | NEW | 新建仓 |
| 3 | ILMN | Illumina Inc | +1.7% | NEW | 新建仓 |
| 4 | QQQ | Invesco Qqq Trust Series 1 | +1.7% | +16.66% | 加仓 |
| 5 | AVTR | Avantor Inc | +1.7% | +1142.57% | 加仓 |
| 6 | IQV | Iqvia Holdings Inc | +1.4% | NEW | 新建仓 |
| 7 | RVTY | Revvity Inc | +1.3% | +70.63% | 加仓 |
| 8 | DVAX | Dynavax Technologies CORP | +1.1% | NEW | 新建仓 |
| 9 | MIRM | Mirum Pharmaceuticals Inc | +1.1% | NEW | 新建仓 |
| 10 | BRKR | Bruker CORP | +1.1% | +68.12% | 加仓 |
| 11 | EOLS | Evolus Inc | +1% | NEW | 新建仓 |
| 12 | GERN | Geron CORP | +1% | NEW | 新建仓 |
| 13 | ICLR | ICON Public Limited Company | +0.7% | +495.82% | 加仓 |
| 14 | REGN | Regeneron Pharmaceuticals | +0.6% | NEW | 新建仓 |
| 15 | VRDN | Viridian Therapeutics Inc | +0.6% | +38.10% | 加仓 |
| 16 | IONS | Ionis Pharmaceuticals Inc | +0.6% | +13.90% | 加仓 |
| 17 | VERA | Vera Therapeutics Inc | +0.5% | +25.50% | 加仓 |
| 18 | TMO | Thermo Fisher Scientific Inc | +0.5% | NEW | 新建仓 |
| 19 | EWTX | Edgewise Therapeutics Inc | +0.5% | NEW | 新建仓 |
| 20 | DHR | Danaher CORP | +0.4% | NEW | 新建仓 |
| 21 | ✓ | Merus N V | +0.3% | +86.16% | 加仓 |
| 22 | TVTX | Travere Therapeutics Inc | +0.3% | +61.11% | 加仓 |
| 23 | CLDX | Celldex Therapeutics Inc | +0.3% | +20.42% | 加仓 |
| 24 | NKTR | Nektar Therapeutics | +0.3% | NEW | 新建仓 |
| 25 | AMRN | Amarin CORP PLC -adr | +0.3% | NEW | 新建仓 |
| 26 | HUM | Humana Inc | +0.2% | +55.95% | 加仓 |
| 27 | TECH | Bio-techne CORP | +0.2% | +40.71% | 加仓 |
| 28 | GPCR | Structure Therapeutics Inc | +0.2% | NEW | 新建仓 |
| 29 | LQDA | Liquidia CORP | +0.2% | +138.46% | 加仓 |
| 30 | ALEC | Alector Inc | +0.2% | +221.67% | 加仓 |
| 31 | RLAY | Relay Therapeutics Inc | +0.2% | NEW | 新建仓 |
| 32 | BCYC | Bicycle Therapeutics Plc-adr | +0.1% | NEW | 新建仓 |
| 33 | NAMS | NewAmsterdam Pharma Company N.V. | +0.1% | +47.51% | 加仓 |
| 34 | PNTG | Pennant Group Inc/the | +0.1% | NEW | 新建仓 |
| 35 | AUTL | Autolus Therapeutics PLC | +0.1% | +77.42% | 加仓 |
| 36 | ARCT | Arcturus Therapeutics Holdin | +0.1% | NEW | 新建仓 |
| 37 | MODVQ | Modivcare Inc | 0% | NEW | 新建仓 |
| 38 | KPTI | Karyopharm Therapeutics Inc | — | — | 不变 |
| 39 | STRO | Sutro Biopharma, Inc. | — | — | 不变 |
| 40 | ACIU | AC Immune SA | — | — | 不变 |
| 41 | PBYI | Puma Biotechnology Inc | — | -12.73% | 减仓 |
| 42 | ELV | Elevance Health Inc | 0% | +20.79% | 加仓 |
| 43 | ETNBGBP | 89bio Inc | 0% | -22.30% | 减仓 |
| 44 | EHTH | Ehealth Inc | 0% | +43.83% | 加仓 |
| 45 | 2662247D | Iteos Therapeutics Inc | 0% | -50.35% | 减仓 |
| 46 | RGEN | Repligen CORP | 0% | +0.91% | 加仓 |
| 47 | IFRX | InflaRx N.V. | -0.1% | -2.12% | 减仓 |
| 48 | MRVI | Maravai Lifesciences Hldgs-a | -0.1% | -32.02% | 减仓 |
| 49 | ZBIO | Zenas Biopharma Inc | -0.1% | -26.96% | 减仓 |
| 50 | XOMA | Xoma Royalty Corporation | -0.1% | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案，Eversept Partners, LP 在 Q2 2025 季度的美股持仓总市值约为 US$19.3亿，共申报了 68 个公开持股仓位。
在 Q2 2025 季度，Eversept Partners, LP 按市值排列的前三大核心持股分别为：NTRA (12.4%)、QQQ (8.7%)、GSK (7.9%)。其中最大持股仓位 NTRA 占据整体投资组合约 12.4% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
UNH
市值: US$1894.8万
本季最大获利了结 / 清仓标的
SPY
前期市值: US$4301.7万
在 Q2 2025 季度中，Eversept Partners, LP 共进行了 70 项持仓异动，包含新建仓 19 个仓位、加仓 23 个仓位、减仓 21 个仓位以及清仓 7 个仓位。 其中最大新建仓标的为 UNH。 本季清仓仓位包含 SPY。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。